{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:43:59Z","timestamp":1707525839287},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,29]]},"DOI":"10.7759\/cureus.53163","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T16:42:07Z","timestamp":1706546527000},"source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Tocilizumab in the Treatment of a Recent Kidney Transplant Recipient With COVID-19"],"prefix":"10.7759","author":[{"given":"Elisabed","family":"Chikobava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasha","family":"Chkhikvadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keti","family":"Menabde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgi","family":"Pkhakadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Tchokhonelidze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200507-073JS","article-title":"Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections","volume":"2","author":"Duncan MD","year":"2005","unstructured":"Duncan MD, Wilkes DS. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc. 2005, 2:449-55. 10.1513\/pats.200507-073JS","journal-title":"Proc Am Thorac Soc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9 Suppl 3","author":"Eckardt K-U","year":"2009","unstructured":"Eckardt K-U, Kasiske BL, Zeier MG. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009, 9 Suppl 3:S1-155. 10.1111\/j.1600-6143.2009.02834.x","journal-title":"Am J Transplant"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010406.pub3","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"2","author":"Lansbury L","year":"2019","unstructured":"Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2019, 2:CD010406. 10.1002\/14651858.CD010406.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard M","year":"2017","unstructured":"Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (Actemra). Hum Vaccin Immunother. 2017, 13:1972-88. 10.1080\/21645515.2017.1316909","journal-title":"Hum Vaccin Immunother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.025","article-title":"Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19","volume":"98","author":"Gade AR","year":"2020","unstructured":"Gade AR, Alavala H, Allam SR. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19. Kidney Int. 2020, 98:1054. 10.1016\/j.kint.2020.06.025","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu X","year":"2020","unstructured":"Xu X, Han M, Li T, et al.. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020, 117:10970-5. 10.1073\/pnas.2005615117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","article-title":"Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy","volume":"19","author":"Toniati P","year":"2020","unstructured":"Toniati P, Piva S, Cattalini M, et al.. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020, 19:102568. 10.1016\/j.autrev.2020.102568","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211079-effectiveness-of-tocilizumab-in-the-treatment-of-a-recent-kidney-transplant-recipient-with-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:42Z","timestamp":1707509682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211079-effectiveness-of-tocilizumab-in-the-treatment-of-a-recent-kidney-transplant-recipient-with-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.53163","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}